Stock HCM HUTCHMED (CHINA) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus HUTCHMED (China) Limited

Equities

HCM

KYG4672N1198

Market Closed - London S.E.
Other stock markets
 16:35:09 26/04/2024 BST 		5-day change 1st Jan Change
290 GBX -4.61% Intraday chart for HUTCHMED (China) Limited +7.41% +2.47%
04-26 EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug MT
04-26 Hutchmed notes CHMP's positive opinion for fruiquintinib approval AN

Evolution of the average Target Price on HUTCHMED (China) Limited

Price target over the last 5 years

History of analyst recommendation changes

0543657014296c902758affdef9.Gqgj-xhq181IyX_W5-n_Og5K3duDL_7JnmYGvS1OMKM.UplwlEs5uKs8sTOHj964D1YsrJHaQo26yjdZ6Wg6Rsp-mRuycj6_vRH7Mg~366d2cb0d2a41883bb0a52c8a191cecb

Analyst Recommendations on HUTCHMED (China) Limited

Deutsche Bank Upgrades HUTCHMED to Buy From Hold, Adjusts Price Target to $22.10 From $20 MT
Goldman Sachs Adjusts Price Target on HUTCHMED (China) to $17 From $15, Maintains Neutral Rating MT
Hutchmed Says Platelet Disorder Drug Increased Durable Response Rate in Phase 3 Trial MT
Goldman Sachs Adjusts HUTCHMED (China)'s Price Target to $16 From $14, Maintains Neutral Rating MT
AstraZeneca Says Lung Cancer Combination Therapy Showed 49% Objective Response Rate MT
AstraZeneca's Lung Cancer Drug Combo Shows 49% Objective Response Rate in Mid-stage Trial MT
Hutchmed Says Phase 2 Study to Treat Patients With MET-Driven Non-Small Lung Cancer Shows Improved Response Rates MT
Deutsche Bank Downgrades HUTCHMED to Hold From Buy, Adjusts Price Target to $20 From $37 MT
HUTCHMED CHINA : Goldman Sachs Downgrades Hutchison China MediTech to Neutral From Buy MT
HUTCHMED CHINA : Jefferies Initiates Hutchison China MediTech at Buy Rating With $52 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.612 USD
Average target price
5.412 USD
Spread / Average Target
+49.84%
High Price Target
7.931 USD
Spread / Highest target
+119.56%
Low Price Target
2.766 USD
Spread / Lowest Target
-23.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering HUTCHMED (China) Limited

Deutsche Bank Securities
Goldman Sachs
Jefferies & Co.

Ratings for HUTCHMED (China) Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HCM Stock
  4. Consensus HUTCHMED (China) Limited